YOLFTbeta
Biotron Ltd

Biotron Ltd

BIT · AU · Healthcare / Biotechnology

0.002AUD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.002
Open0.002
Day Range0.002 – 0.002
52-Week Range0.0015 – 0.005
Volume220.00K
Market Cap5.57M
P/E (TTM)0.00
Forward P/E11.92
EPS0.00
Dividend Yield0.00%
Beta-0.64
50-Day Avg0.0021
200-Day Avg0.0026

About

Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225 that is in Phase 2 clinical trial for the treatment of HIV-1, as well as to treat hepatitis C virus infections; and BIT-HBV001 to treat hepatitis B virus and hepatitis delta virus. It also develops preclinical drugs for viral diseases, such as dengue, zika, and influenza virus. The company was incorporated in 1999 and is based in Sydney, Australia.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEODr. Michelle Miller BSc., GCertAppFin, MSc., Ph.D.
  • Employees0
  • Headquarters66 Hunter Street, Sydney, NSW, Australia, 2000, Australia
  • Websitehttps://www.biotron.com.au

Leadership

  • Dr. Michelle Miller BSc., GCertAppFin, MSc., Ph.D.MD & Executive Director
  • Mr. Marcelo Mora ACIS, B.Bus AasaCompany Secretary

Financials

Income Statement

Currency: AUD2000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue-13.06K62.74K299.00K187.00K133.00K794.86K402.46K-----891.95K1.72M1.67M1.55M1.66M1.62M1.07M803.03K1.46M1.56M1.43M1.65M1.81M-
Growth (%)--+380.40%+376.57%-37.46%-28.88%+497.64%-49.37%------+93.11%-2.92%-7.42%+7.19%-2.22%-33.88%-25.15%+82.05%+6.61%-8.16%+14.94%+10.24%-
Cost of Revenue---82.00K120.00K83.00K45.00K44.00K------02.88M15.46K13.07K11.64K12.47K50.12K47.34K45.26K43.34K40.50K11.10K1.91K
Gross Profit-13.06K62.74K---794.86K402.46K-----891.95K1.72M1.67M1.53M1.65M1.61M1.06M752.91K1.41M1.51M1.39M1.65M1.81M-1.91K
Gross Margin-100.00%100.00%---100.00%100.00%-----100.00%100.00%100.00%99.00%99.21%99.28%98.84%93.76%96.76%97.10%96.97%100.00%100.00%-
Operating Expense-1.55M2.07M---3.09M3.79M-----5.85M4.88M4.44M5.86M6.04M3.22M3.83M4.80M5.73M4.29M6.43M6.80M2.15M1.93M
Operating Income--1.53M-2.01M-2.65M-3.51M-2.64M-2.30M-3.39M-2.39M-1.84M-1.92M-2.42M-3.09M-4.95M-3.16M-2.77M-4.32M-4.40M-1.61M-2.77M-4.05M-4.32M-2.78M-5.04M-5.15M-338.75K-1.93M
Operating Margin--11738.93%-3202.27%-887.55%-1878.37%-1983.17%-289.22%-842.32%------555.46%-183.21%-165.70%-279.22%-264.92%-99.24%-258.55%-504.16%-295.29%-178.32%-352.04%-313.12%-18.68%-
EBITDA--1.53M-1.81M-2.44M-3.33M-1.75M-2.12M-3.34M-1.84M-1.73M-1.85M-1.89M-2.37M-4.73M-3.07M-4.38M-4.54M-4.69M-3.20M-2.67M-4.27M-4.56M-2.73M-4.88M-5.04M-333.81K-1.93M
EBITDA Margin--11699.75%-2892.79%-816.79%-1780.59%-1312.72%-266.20%-829.52%------530.80%-178.50%-261.83%-293.06%-282.86%-197.44%-249.08%-532.21%-311.76%-175.22%-340.66%-306.37%-18.41%-
Net Income--1.28M-1.67M-2.73M--1.88M-2.20M-3.23M-1.88M-1.78M-1.87M-1.91M-2.38M-3.85M-3.09M-2.72M-3.00M-3.09M-1.59M-1.61M-3.58M-3.19M-2.78M-3.49M-3.44M-318.57K-1.52M
Net Income Margin--9800.92%-2657.00%-912.61%--1416.22%-276.65%-803.57%------431.72%-179.15%-162.85%-194.05%-186.41%-98.22%-150.24%-445.31%-218.50%-178.44%-244.03%-208.89%-17.57%-
R&D41.00K542.24K1.06M1.20M2.08M1.40M1.88M2.41M1.30M980.29K965.31K1.16M1.73M3.55M3.24M2.88M3.13M3.16M1.69M1.12M2.86M3.14M2.82M3.23M3.62M535.42K683.30K
R&D as % of Total Revenue-4151.92%1694.29%400.34%1113.05%1055.70%235.95%599.42%-----397.50%187.94%172.40%202.31%190.15%104.32%104.01%355.83%214.55%181.01%225.84%220.34%29.52%-
Interest Expense0095100000000000000005.12K5.12K1.26K5.05K4.39K1.09K14.63K-
Interest Expense % of Total Revenue-0.00%1.52%0.00%0.00%0.00%0.00%0.00%-----0.00%0.00%0.00%0.00%0.00%0.00%0.48%0.64%0.09%0.32%0.31%0.07%0.81%-

Balance Sheet

Currency: AUD2000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets42.22M10.19M8.63M5.91M3.11M2.43M4.81M1.52M2.27M1.06M1.86M2.64M8.46M4.87M1.86M4.62M3.48M2.06M1.62M5.86M7.83M4.33M1.91M4.14M493.48K980.40K3.74M
Total Liabilities22.00K111.45K142.90K148.08K153.33K149.88K318.11K163.02K423.94K222.33K140.29K244.32K192.18K391.08K474.64K473.18K346.32K619.51K337.70K418.00K853.19K463.51K813.57K962.49K737.51K428.51K817.93K
Total Equity42.22M10.08M8.49M5.76M2.96M2.28M4.50M1.36M1.84M841.51K1.72M2.40M8.27M4.48M1.39M4.14M3.14M1.44M1.28M5.44M6.97M3.86M1.09M3.17M-244.03K551.89K2.92M
Cash11.02M9.71M7.58M5.38M2.62M2.11M4.62M1.38M2.06M950.58K1.78M2.14M7.89M4.79M1.76M4.52M3.42M1.99M1.54M5.74M7.66M4.21M1.74M3.98M393.20K931.68K1.55M
Total Debt-------------------44.02K44.02K6.35K77.24K45.27K7.13K--
Net Debt-11.02M-9.71M-7.58M-5.38M-2.62M-2.11M-4.62M-1.38M-2.06M-950.58K-1.78M-2.14M-7.89M-4.79M-1.76M-4.52M-3.42M-1.99M-1.54M-5.74M-7.62M-4.20M-1.66M-3.94M-386.07K-931.68K-1.55M

Cash Flow

Currency: AUD2000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow--1.31M-1.68M--2.61M-1.71M-1.79M-3.65M-1.62M-1.89M-1.86M-1.97M-2.29M-3.09M-2.98M-2.72M-3.08M-2.83M-1.84M-1.50M-3.08M-3.41M-2.44M-3.29M-3.57M-565.80K-1.78M
Investing Cash Flow--273.00K-481.00K-80.48K-151.93K-546-1.21K400.26K-62.26K5.00K-1.86M-1.82K-2.25K-8.73K-52.41K-4.76K-4.76K-11.91K-52.88K-52.88K-5.72K-5.72K000-3.07K111.51K
Financing Cash Flow262.00K11.15M28.00K--1.21M4.30M-2.37M774.23K2.69M2.33M8.04M-5.48M5.48M1.96M1.41M1.40M5.75M5.00M-36.96K-33.17K5.53M-22.62K1.11M2.29M
Capital Expenditure0273.00K481.00K80.48K154.95K5461.21K2.19K62.26K001.82K2.25K8.73K52.41K4.76K4.76K5.50K40.93K40.93K5.72K5.72K0543.07K4
Free Cash Flow--1.58M-2.16M-80.48K-2.76M-1.71M-1.79M-3.65M-1.68M-1.89M-1.86M-1.97M-2.29M-3.10M-3.03M-2.72M-3.09M-2.84M-1.84M-1.54M-3.08M-3.41M-2.44M-3.29M-3.57M-568.87K-1.78M
Dividends Paid----------------00--4.73M--5.11M---
FCF to OCF-120.83%128.59%-105.95%100.03%100.07%100.06%103.84%100.00%100.00%100.09%100.10%100.28%101.76%100.00%100.15%100.19%100.00%102.73%100.00%100.17%100.00%100.00%100.00%100.54%100.00%
Dividend Paid to FCF----------------0.00%0.00%---153.40%---155.17%---

Earnings

Report DateFeb 26, 2016Aug 5, 2016Feb 24, 2017Aug 28, 2017Feb 23, 2018Aug 29, 2018Feb 20, 2019Aug 28, 2019Feb 26, 2020Aug 27, 2020Feb 23, 2021Aug 27, 2021Feb 23, 2022Aug 19, 2022Feb 17, 2023Feb 28, 2025Aug 27, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
EPS Actual-0.010.00-0.010.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Surprise-----------------
Timing-------------After-hoursAfter-hours--

Key Statistics & Ratios

Market Cap5.57M
Enterprise Value4.02M
Trailing P/E0.00
Forward P/E11.92
PEG Ratio0.00
Price / Sales10.59
Price / Book1.91
EPS0.00
Book Value0.001
Revenue (TTM)525.87K
Gross Profit (TTM)525.87K
EBITDA-1.55M
Profit Margin-288.72%
Operating Margin-118.85%
Return on Equity-87.44%
Return on Assets-41.22%
Shares Outstanding2.79B
Shares Float1.96B
Beta-0.64
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Mar 5, 20258:7
  • Oct 31, 2022222:215
  • May 15, 2018140:127
  • May 29, 201765:62
  • Oct 17, 201433:31
  • Mar 27, 2006126:121